Search Results 41-50 of 17298 for hba1c

1. Examination of the Pancreas in New-onset Diabetes - Mayo Clinic

   HbA1C ≥ 6.5%. No acute illness or steroid therapy; No prior pancreas surgery. Participating Mayo Clinic locations. Study statuses change often. Please contact ...

2. Diabetes - Symptoms and causes - Mayo Clinic

   Diabetes mellitus refers to a group of diseases that affect how the body uses blood sugar (glucose). Glucose is an important source of energy for the cells that ...

3. A Comparative Effectiveness Study Of Major Glycemia-lowering Medications For Treatment Of Type 2 Diabetes - Mayo Clinic

   HbA1c criteria (at final run-in visit, ~2 weeks prior to randomization): 6.8-8.5%; Taking a daily dose of ≥ 1000 mg metformin for a minimum of 8 weeks at ...

4. Impact Of Aromatase Inhibitor Therapy On Glucose Homeostasis And Diabetes Risk - Mayo Clinic

   ... HbA1c ≥ 6.5% * History of upper GI surgery that alters gastric emptying or causing malabsorption e.g., bariatric surgery, fundoplication. Note: Other ...

5. Effects Of Niacin On Intramyocellular Fatty Acid Trafficking In Upper Body Obesity And Type 2 Diabetes Mellitus - Mayo Clinic

   HbA1C < 6.5% for non-diabetic UBO; Fasting glucose < 126 mg/dl for non-diabetic UBO; Hb ≥ 11.0 for women and ≥ 12 for men; platelets > 100 000. Exclusion ...

6. RESET System Pivotal Trial (Rev F) - Mayo Clinic

   HbA1c ≥ 7.5% and ≤10%. BMI ≥30kg/m2 and ≤ 50kg/m2. Willing and able to comply with study requirements. Documented negative pregnancy test in women of ...

7. A Prospective Study to Establish a New Onset Hyperglycemia and Diabetes (NOD) Cohort - Mayo Clinic

   Hemoglobin A1c (HbA1c) ≥ 6.5% present; or; Any (2) PDMs present on consecutive or simultaneous testing: Fasting Blood Glucose (FBG) ≥ 126 mg/dl;; Hemoglobin ...

8. A Study to Evaluate the Effect of Hyperoxia on Glucose Metabolism in Type 2 Diabetics - Mayo Clinic

   HbA1c 6.5% -9.5%; FPG ≥126 mg/dL (7.0 mmol/L) <270 mg/dl at screening; 25 to 60 years of age; BMI 22-37 kg/m². Exclusion Criteria. Diabetic meds other than ...

9. A Study Of Continuous Glucose Monitoring In Individuals 60 Years Old Or Older With Type 1 Diabetes - Mayo Clinic

   Age ≥60 years; HbA1c <10.0% at screening or within 30 days prior to screening visit (the upper limit was selected as a surrogate measure of likelihood of ...

10. A Study To Evaluate The Effectiveness And Safety Of Exenatide SR For Diabetes Prevention Following Kidney Transplantation - Mayo Clinic

    The purpose of this study is to compare the rate of progression from prediabetes at 4 months to frank diabetes at 12 months (as defined by increase in HbA1C ...